Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Medical Affairs Pharma

- PMLiVE

Pfizer/BioNTech BA.4/BA.5 COVID-19 booster approved for emergency use by FDA in children five to 11 years

The doses will be shipped immediately, pending recommendation from the CDC

Thought Leaders in Medical Affairs: Key Trends & Challenges Shaping the Future of the Medical Affairs Role

How can Medical Affairs divisions bring greater value to their organizations and practitioners every day?

Medscape Medical Affairs

- PMLiVE

Pfizer completes acquisition of Global Blood Therapeutics for $5.4bn

The deal includes a pipeline of sickle cell disease targeted treatments including Oxbryta

Mobilizing Agitation Detection in Children with ADHD

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Impetus Digital

The Medscape Medical Affairs Difference

What is so different about Medscape Medical Affairs in this crowdedMedical Communications landscape?

Medscape Medical Affairs

- PMLiVE

Leveraging KOL insights to succeed in a data-driven world

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in...

Medscape Medical Affairs

- PMLiVE

Pfizer’s Talzenna combination treatment meets primary endpoint in phase 3 prostate cancer study

An improvement in radiographic progression-free survival was demonstrated

- PMLiVE

Medscape Medical Affairs

Medscape's New Unit to Support Pharmaceutical Medical Affairs

Medscape Medical Affairs

Modern Medical Affairs: How to Leverage Tech and Data as an MSL

Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...

Impetus Digital

Is communication failing us?

Compelling people to care in a world oversaturated with news and information

Page & Page and Partners

- PMLiVE

Pfizer and BioNTech seek FDA authorisation for COVID-19 booster for children

An application will also be submitted to the European Medicines Agency to extend the marketing authorisation for this age group

- PMLiVE

Pfizer and Sangamo Therapeutics reopen recruitment for haemophilia A gene therapy trial

The trial was voluntarily paused by the two partners last year and later placed on hold by the FDA

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links